Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Mersana Therapeutics Inc MRSN

Mersana Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which is focused on the development of antibody-drug conjugates (ADCs), which offer a clinically meaningful benefit for cancer patients with significant unmet needs. It has developed two proprietary and differentiated ADC platforms: Dolasynthen and Immunosynthen. Dolasynthen is its cytotoxic ADC platform that is designed... see more

Bullboard (NDAQ:MRSN)

View:
User Avatar Image
(280)
•••
  • whytestocksX
Post by whytestockson Nov 13, 2024 10:30am

Mersana Therapeutics Provides Business Update and Announces

News; $MRSN Mersana Therapeutics Provides Business Update and Announces Third Quarter 2024 Financial ResultsPlan to announce initial clinical data for XMT-1660 at a company event by the end of 2024 ...more  
User Avatar Image
(280)
•••
  • whytestocksX
Post by whytestockson Nov 06, 2024 3:34pm

Mersana Therapeutics to Host Third Quarter 2024 Conference C

Just In: $MRSN Mersana Therapeutics to Host Third Quarter 2024 Conference Call on November 13, 2024CAMBRIDGE, Mass., Nov. 06, 2024 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (NASDAQ: MRSN), a ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities